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Abstract
Mechanistic studies of RNA processing in the RNA-Induced Silencing Complex (RISC)
have been hindered by lack of methods for continuous monitoring of enzymatic activity.
“Quencherless” fluorogenic substrates of RNAi enzymes enable continuous monitoring of
enzymatic reactions for detailed kinetics studies. Recombinant RISC enzymes cleave the
fluorogenic substrates targeting human thymidylate synthase (TYMS) and hypoxia-
inducible factor 1-α subunit (HIF1A). Using fluorogenic dsRNA DICER substrates and
fluorogenic siRNA, DICER+ARGONAUTE2 mixtures exhibit synergistic enzymatic activity
relative to either enzyme alone, and addition of TRBP does not enhance the apparent activi-
ty. Titration of AGO2 and DICER in enzyme assays suggests that AGO2 and DICER form a
functional high-affinity complex in equimolar ratio. DICER and DICER+AGO2 exhibit Mi-
chaelis-Menten kinetics with DICER substrates. However, AGO2 cannot process the fluoro-
genic siRNA without DICER enzyme, suggesting that AGO2 cannot self-load siRNA into its
active site. The DICER+AGO2 combination processes the fluorogenic siRNA substrate
(Km=74 nM) with substrate inhibition kinetics (Ki=105 nM), demonstrating experimentally
that siRNA binds two different sites that affect Dicing and AGO2-loading reactions in RISC.
This result suggests that siRNA (product of DICER) bound in the active site of DICERmay
undergo direct transfer (as AGO2 substrate) to the active site of AGO2 in the DICER+AGO2
complex. Competitive substrate assays indicate that DICER+AGO2 cleavage of fluorogenic
siRNA is specific, since unlabeled siRNA and DICER substrates serve as competing sub-
strates that cause a concentration-dependent decrease in fluorescent rates. Competitive
substrate assays of a series of DICER substrates in vitro were correlated with cell-based as-
says of HIF1AmRNA knockdown (log-log slope=0.29), suggesting that improved DICER
substrate designs with 10-fold greater processing by the DICER+AGO2 complex can pro-
vide a strong (~2800-fold) improvement in potency for mRNA knockdown. This study lays
PLOSONE | DOI:10.1371/journal.pone.0120614 March 20, 2015 1 / 21
a11111
OPEN ACCESS
Citation: Bernard MA, Wang L, Tachado SD (2015)
DICER-ARGONAUTE2 Complex in Continuous
Fluorogenic Assays of RNA Interference Enzymes.
PLoS ONE 10(3): e0120614. doi:10.1371/journal.
pone.0120614
Academic Editor: Christophe Antoniewski, CNRS
UMR7622 & University Paris 6 Pierre-et-Marie-Curie,
FRANCE
Received: May 27, 2014
Accepted: February 5, 2015
Published: March 20, 2015
Copyright: © 2015 Bernard et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: MAB and LW received salary from Pfizer
Inc. but are no longer affiliated with Pfizer. This work
was supported by the National Institutes of Health
grant 2R56HL092811 (to SDT). The National
Institutes of Health had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript. Pfizer Oligonucleotide
Therapeutics Unit had a role in funding, study design,
data collection and analysis, and gave permission to
publish the manuscript, but had no role in manuscript
the foundation of a systematic biochemical approach to optimize nucleic acid-based thera-
peutics for Dicing and ARGONAUTE2-loading for improving efficacy.
Introduction
RNA interference brings about silencing of specific genes by sequence-specific degradation of
mRNA [1]. Micro RNA precursors are derived from primary RNA transcripts that can form
intramolecular hairpins (pri-miRNA), which can be cleaved in the nucleus by the endonuclease
DROSHA to produce hairpin loops with a 3’ dinucleotide overhang called pre-microRNAs [2].
Pre-miRNAs are then exported via nuclear export receptor, Exportin-5 into the cytoplasm
[2,3] for endonucleolytic processing by the RNA-Induced Silencing Complex (RISC) consisting
of DICER, ARGONAUTE and the human immunodeficiency virus-1 transactivating response
RNA-binding protein TRBP [4]. The cytoplasmic endonuclease, DICER binds the 3’-overhang
and cleaves in a staggered fashion to yield an additional 3’ dinucleotide overhang on the oppo-
site end in which each strand of the resulting double-stranded short interfering RNA (siRNA)
is 21- to 23-nt long [5,6]. A complex of DICER and the dsRNA-binding protein TRBP is re-
ported to be involved in microRNA processing and AGO-loading [7], although TRBP is dis-
pensable in vitro [8,9]. The endonuclease ARGONAUTE2 (AGO2) binds one of the strands as
the Guide Strand and is thus programmed to make single-strand cleavages in mRNA at a site
complementary to the Guide Strand residing in the active site of AGO2 [10].
In the current enzyme kinetics study, we describe novel enzymatic assays of DICER and
AGO2-loading with continuous monitoring of fluorescence intensity. New mechanistic in-
sights were gained using fluorogenic dsRNA substrate molecules. This study provides a system-
atic biochemical approach to optimize nucleic acid-based therapeutics for Dicing and AGO2-
loading in order to improve efficacy. Using purified recombinant human RNAi proteins to
reconstitute the RISC complex in vitro, DICER loads the endonuclease ARGONAUTE2 with a
double-stranded siRNA possibly in a direct transfer mechanism, resulting in enzymatic cleav-
age. Competitive enzyme kinetic assays of AGO2 loading were correlated with mRNA knock-
down in cell-based assays targeting hypoxia inducible factor 1-α (HIF1A). This report
describes a new technology for continuous assay of DICER and AGO2 enzymatic activities that
enables biochemical evaluation of new designs of nucleic-acid therapeutic candidates. The
RNA interference apparatus of cells may allow new therapies: nucleic-acid based drugs that tar-
get previously undruggable targets by specifically cleaving the messenger RNA.
Materials and Methods
Ribonuclease H (Escherichia coli) was from Promega (Madison, WI). BODIPY FL-dextran
conjugate was from Invitrogen (Carlsbad, CA). NBS-coated 384-well plates with black wells
were from Corning Life Sciences (Lowell, MA). Mineral oil (Nujol oil) was from PerkinElmer
Life And Analytical Sciences, Inc. (Waltham, MA). iCycler iQ 96-well PCR plates, Microseal
‘B’ Film and an iCycler iQ5 multicolor real-time PCR instrument were from Bio-Rad Laborato-
ries (Hercules, CA). SeeBlue Plus2 pre-stained standard was from Invitrogen (Carlsbad, CA).
Single-stranded oligonucleotide designs are shown in Table 1. RNA oligonucleotides with the
5’-phosphate modification were synthesized and purified by Invitrogen (Carlsbad, CA). RNA
oligos BoGD664AS, BoPD664S, BoPD664s-dAdG and BoPsi664S were individually conjugated
to BODIPY FL dye with an aminohexyl linkage to the 5’-phosphate and purified to>97% full-
length product by Invitrogen (Carlsbad, CA). Oligoribonucleotide S955 was synthesized and
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purified by Dharmacon (Lafayette, CO). AllStars Negative Control siRNA (a non-silencing
siRNA) was from Qiagen, Inc. (Valencia, CA). Unlabeled DICER substrates were synthesized
and purified by IDT (Coralville, IA) or by the Pfizer Oligonucleotide Therapeutics Unit (Cam-
bridge, MA). The hepatocarcinoma cell line Huh-7.5 was from the American Type Culture
Collection (Manassas, VA).
All data are contained in the paper. Baculovirus expressing human AGO2 enzyme, DICER
enzyme and TRBP used in this study had been discarded by Pfizer, Inc. during the company’s
reorganization. All other materials are commercially available. Other researchers can reproduce
the current study using similar materials. DICER is available from Life Technologies (catalog
no. K3600–01 and K3650–01) and Genlantis (San Diego, CA; catalog no. T510001). AGO2 is
available from Sino Biological Inc. (catalog no. 11079-H07B-10). TRBP (TARBP2) is available
from OriGene Technologies (catalog no. PH301043) and Abcam (catalog no. ab181920).
Melting analysis of dsRNA strands (fluorescence vs. UV absorbance
detection) and fluorescence quenching upon duplex formation
Duplexes (10 μM in TE Buffer) were denatured at 95°C in PCR tubes on VWRModular Heat-
ing Blocks, and the blocks were transferred to the bench top for gradual annealing. Duplexes
were diluted to 200 nM in Mg-Containing Buffer (50 mMHEPES, pH 7.5, 20 mM KCl, 1 mM
MgCl2) or “Divalent Cation-Free Buffer” (50 mMHEPES, pH 7.5, 20 mM KCl, 5 mM EDTA).
Similarly, dilutions of fluorescent ssRNA strand (BoPsi644S) were prepared for linear calibra-
tion of fluorescence intensity as a function of temperature vs. concentration of unquenched
ssRNA strand. Fluorescence intensity was monitored using a 7900HT Fast Real-Time PCR Sys-
tem (Applied Biosystems, Foster City, CA). The instrument was configured for Absolute
Table 1. Oligoribonucleotide sequences of ﬂuorogenic substrates.
ORN Strand Sequence
BoGD664AS AS BODIPY FL-aminohexyl-5'-PO4-CUGGUGAGGAAUGGGUUCACAAAUCAGtt-3'
GD664S S 5'-PO4-CUGAUUUGUGAACCCAUUCCUCACCAG-3'
GD664dAdG-S S 5'-PO4-CUGAUUUGUGAACCCAUUCCUCACCag-3'
BoPD664S S BODIPY FL-aminohexyl-5'-PO4-CUGAUUUGUGAACCCAUUCCUCACCAG-3'
BoPD664S-dAdG S BODIPY FL-aminohexyl-5'-PO4-CUGAUUUGUGAACCCAUUCCUCACCag-3'
PD664AS AS 5'-PO4-CUGGUGAGGAAUGGGUUCACAAAUCAGtt-3'
BoPsi664S S BODIPY FL-aminohexyl-5'-PO4-CUGAUUUGUGAACCCAUUCtt-3'
Psi664AS AS 5'-PO4-GAAUGGGUUCACAAAUCAGtt-3'
S955 S 5’-GGAGCUUGAAGGAUAUUGUCAGUCUUUAGGGGUUGGGCUGGAUGCCGAGG-3’
Bo995Ra AS BODIPY FL-aminohexyl-5’-PO4-CUGACAAUAUCCUUCAAGCUCCUU-3'
Bo995Rb AS BODIPY FL-aminohexyl-5’-PO4-CUAAAGACUGACAAUAUCCUUCAAGCUCCUU-3'
Bo995Rb5 AS BODIPY FL-aminohexyl-5’-PO4-CUAAAGACUG-3'
2’-Deoxyribonucleotides are shown in boldface underscored lower case.
S: Sense strand.
AS: Anti-sense strand.
BoGD664 (Guide-strand labeled dsRNA): GD664S * BoGD664AS duplex.
BoGD664dAdG (Guide-strand labeled dsRNA): GD664dAdG-S * BoGD664AS duplex BoPD664 (Passenger-strand labeled dsRNA): BoPD664S *
PD664AS duplex.
BoPD664dAdG (Passenger-strand labeled dsRNA): BoPD664dAdG-S * PD664AS duplex BoPsi664 (Passenger-strand labeled siRNA): BoPsi664S *
Psi664AS duplex.
doi:10.1371/journal.pone.0120614.t001
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Quantitation mode to monitor channel #7 during thermal denaturation and annealing; tem-
perature was slowly adjusted (25–4°C, 4–95°C and 95–4°C) in Standard Block mode (ramp
rate of 1%, i.e. -0.59°C/min for cooling and +0.50°C/min for warming). Absorbance (λ = 260
nm) was also monitored for duplexes undergoing thermal denaturation and annealing in 1-cm
quartz mini-cells using a Cary 100 Bio UV-visible spectrophotometer configured with the 6×6
Multicell Block Peltier Series II and Temperature Controller accessory (Agilent Technologies,
Santa Clara, CA); temperature was adjusted slowly from 20–4°C, 4–90°C and 90–4°C at a ramp
rate of 0.50°C/min.
Protein expression and purification
Recombinant human RISC proteins (AGO2, DICER1 and the TARBP2 variant of TRBP) were
expressed in an insect baculovirus system using the Titerless Infected cells Preservation and
Scale-up (TIPS) method [11–13]. Baculoviruses were generated using the Bac-to-Bac system
(Invitrogen). Human AGO2, DICER and TRBP were engineered to express the full-length pro-
tein with a 6×histidine tag (N-terminal tag for AGO2 and TRBP, C-terminal tag for DICER),
and TEV protease cutting site was inserted between the ORF and His tag for purification pur-
poses. All constructs were verified with double strand sequencing.
RISC proteins were purified using three common steps: nickel affinity, reverse nickel affinity
and size-exclusion chromatography. Briefly, 1L of cells was suspended in 100 mL lysis buffer
(Buffer NA) containing 50 mM Tris pH 8.0, 500 mMNaCl, 5% glycerol, 5 mM Tris(2-carbox-
yethyl)phosphine (TCEP) and protease inhibitors. The cells were lysed with a microfluidizer
(Watts Fluidair). The insoluble protein and cell debris were sedimented through a 2-hour cen-
trifugation at 40,000×g (4°C). The supernatant was filtered and loaded with 5 mM imidazole
onto a HisTrap HP column (GE Bioscience) equilibrated with 0.5% Buffer NB (Buffer NA con-
taining 1M imidazole). For AGO2 purification, both buffer NA and NB also contained 0.1%
Triton X-100. The column was step-washed/eluted with 0.5, 2.5, 5, 10, 30% buffer NB. The
fractions containing corresponding proteins were pooled. TEV protease was added to a final
concentration 50 units/mg protein and dialyzed against Buffer NA overnight (4°C) to remove
the His tag. The dialyzed proteins were then applied to a HisTrap HP column, and the un-
bound proteins were pooled and concentrated to 3 mL. The concentrated proteins were further
purified through a size-exclusion column Superdex 200 16/60 equilibrated with gel filtration
buffer (50 mM Tris pH 8.0, 300 mMNaCl, 0.5 mM EDTA, 10% glycerol and 2 mM DTT) with
a flow-rate at 1 mL/min. Fractions containing corresponding proteins were pooled and concen-
trated. The protein concentrations were measured using Bio-Rad Bradford assay with BSA as
standard. Proteins were flash-frozen in liquid nitrogen and stored at -80°C. Purified proteins
were analyzed on a NuPAGE Bis-Tris 4–12% gel with MES running buffer followed by Coo-
massie Blue staining (Invitrogen, Carlsbad, CA).
Continuous enzymatic assay of DICER activity and DICER-dependent
AGO2-loading activity
BODIPY FL-dextran was diluted in Assay Buffer (50 mMHEPES, pH 7.5, 10 mM KCl, 2.0 mM
MgCl2, 0.5 mM EDTA, 0.5 mM EGTA, 1 mM phenylmethylsulfonyl fluoride and 1 mM dithio-
threitol), to several concentrations ranging from 0–350 nM of fluorescent dye. BODIPY FL-
dextran was applied to a 384-well plate (40 μL/well), and mineral oil (20 μL/well) was layered
on top of the aqueous solution to prevent evaporation. Fluorogenic substrates were diluted in
Assay Buffer, applied to a 384-well plate, and mineral oil (20 μL/well) was layered on top of the
solution. Assays that include EDTA controls used Assay Buffer containing the indicated con-
centration of EDTA, 20 mM KCl or NaCl and no MgCl2. Well contents were de-gassed by
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centrifuging the plate for 60 s. under vacuum using the swinging-bucket A-2-VC rotor of a
Vacufuge Plus centrifuge (Eppendorf, Westbury, NY). Substrate equilibration was monitored
(excitation 488 nm, emission 520 nm, cut-off 515 nm, high gain) in SpectraMax Gemini or M5
spectrofluorometers (Molecular Devices, Sunnyvale, CA) for 2 hr at 37°C. Recombinant
human RNAi protein mixtures (AGO2, DICER, TRBP or combinations thereof) in Assay Buff-
er or E. coli RNAse H were applied to wells and mixed using a multi-channel pipette. The final
reaction mixtures were de-gassed by centrifuging the plate again for 60 s. under vacuum in the
A-2-VC rotor of an Eppendorf Vacufuge Plus centrifuge, and fluorescence intensity was moni-
tored in a microplate spectrofluorometer for 18 hrs at 37°C.
Thermal denaturation analysis of reaction products
For each digestion, 25 μL of the aqueous contents of duplicate reaction wells were transferred
to a 96-well PCR plate and sealed with Microseal ‘B’ Film. The plate was centrifuged for 2 min
at 4°C (1000×g in a GH-3.8 rotor of an Allegra 6KR centrifuge; Beckman-Coulter, Palo Alto,
CA). The plate was placed in an iCycler iQ5 Real Time system (Bio-Rad Laboratories, Hercules,
CA) and brought to 37°C followed by slow annealing (-0.5°C/min) to 4°C. The plate was slowly
warmed from 4–22°C (1°C/min) followed by 22–24°C (0.25°C/min). Thermal denaturation
(ramped slowly from 24–95°C at 1°C/min) was recorded using the FITC filter set. The temper-
ature dependence of the fluorescence intensity was taken into account: at each temperature the
raw fluorescence intensities of the digestion products were converted to the concentration of
unquenched BODIPY FL dye by computing the linear relationship between fluorescence inten-
sity vs. BODIPY FL-ssRNA concentration at each respective temperature.
Enzymatic AGO-loading in the DICER-AGO2 complex by competitive
substrate assay
The fluorogenic AGO substrate BoPsi664 in Assay Buffer was applied (20 μL/well) to a 384-
well plate, and mineral oil (20 μL/well) was layered on top of the solution. Well contents were
de-gassed by centrifuging the plate for 60 s. under vacuum using the swinging-bucket A-2-VC
rotor of a Vacufuge Plus centrifuge (Eppendorf, Westbury, NY). The plate was incubated 2hr
at 37°C. Unlabeled competing substrate in Assay Buffer was injected into the lower phase and
mixed (15 μL/well). The plate was degassed as before, and substrate equilibration was moni-
tored (excitation 488 nm, emission 520 nm, cut-off 515 nm, high gain) using a SpectraMax
Gemini spectrofluorometer (Molecular Devices, Sunnyvale, CA) for 2 hr at 37°C. Recombinant
human DICER+AGO2 in Assay Buffer was injected (5 μL/well) and the lower phase was mixed
using a multi-channel pipette. The final reaction mixtures containing DICER+AGO2 (30 nM
each), the fluorogenic siRNA BoPsi664 (80 nM) and indicated concentration of unlabeled
DICER substrate or unlabeled siRNA in Assay Buffer were de-gassed as before, and fluores-
cence intensity was monitored in the microplate spectrofluorometer for 18 hr at 37°C. The ap-
parent initial rates of increased fluorescence intensity were plotted as a function of the
logarithm of competing substrate concentration. IC50 values were calculated using GraphPad
Prism software (GraphPad Software, San Diego, CA).
Cell assays for knockdown of HIF1A
Hepatocarcinoma cell line Huh-7.5 was treated with DICER substrates (Table 1) or non-silenc-
ing AllStars Negative Control siRNA. Cell extracts were analyzed for knockdown ofHIF1A
mRNA using the Panomics branched DNA (bDNA) assay (Affymetrix, Santa Clara, CA) ac-
cording to the manufacturer’s instructions. The EC50 values for mRNA knockdown were calcu-
lated using GraphPad Prism software (GraphPad Software, San Diego, CA).
DICER-ARGONAUTE2 Complex in RNAi Fluorogenic Assay
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Results
Principle of fluorogenic assays for DICER and AGO2 enzymatic activity
The new fluorogenic assay allows continuous monitoring for enzyme kinetics studies. The fluo-
rescent dye BODIPY FL is conjugated to the phosphate of the 5’-terminal cytosine of one RNA
strand. The labeled BODIPY-RNA strand is annealed to a nucleic acid in which a complemen-
tary guanosine residue is base paired directly opposite the fluorescently labeled cytosine. The
guanine nucleobase serves as a natural quencher of BODIPY FL [14–16]. Cleavage of fluoro-
genic duplex substrates of DICER and AGO2 produces short, unstable duplexes that dissociate
at assay temperature (37°C) resulting in increased fluorescence intensity (Fig. 1). Sequences of
individual strands are shown in Table 1. Names of ssRNA sense and antisense strands are de-
noted with the suffix “S” or “AS,” respectively. Names of fluorogenic duplex substrates lack the
suffix. Fluorogenic substrates and cleavage products can be analyzed by thermal denaturation
and annealing without adding exogenous intercalating fluorescent dyes.
Duplexing and quenching analysis of fluorogenic dsRNA substrates
We analyzed RNAi substrates that target humanHIF1A including the DICER substrate
BoGD664, BoPD664 and fluorogenic siRNA BoPsi664 to determine whether the stability of
BODIPY FL-labeled dsRNA duplexes can be measured fluorimetrically. By slowly increasing
or decreasing temperature, we measured the melting and annealing of BODIPY FL-dsRNA du-
plexes by conventional UV spectrophotometry (Absorbance at 260 nm), and melting tempera-
tures (Tm) were measured at the peak of first derivative (dA260/dT). Thus, DICER substrate
BoGD664, BoPD664 and fluorogenic siRNA BoPsi664 had UV Tm of 83.0, 82.5 and 71.3°C, re-
spectively (Fig. 2A-C, upper panels). During slow annealing, fluorimetric measurements of
unquenched strand concentration as a function of temperature C(T) and total unquenched
strand concentration measured at T = 95°C, C(95) were recorded using an 7900HT Real Time
PCR System (Applied Biosystems Inc., Foster City, CA). The fraction of unquenched strands
was given by C(T)/C(95), and the fluorimetric Tm was measured at the peak of the first deriva-
tive with respect to temperature. The UVmelting temperatures for BoGD664, BoPD664 and
BoPsi664 (Fig. 2A-C, upper panels) were consistent with the fluorimetric Tm of 83.4, 83.4 and
72.2°C, respectively (Fig. 2A-C, lower panels). The effect of divalent cations on duplex stability
was tested by addition of EDTA, which decreased the fluorimetric melting temperatures of
BoGD664, BoPD664 and BoPsi664 (ΔTm = -11.4, -11.2 and -11.4°C, respectively).
Next, quenching of BODIPY FL-RNA was tested for any effect on fluorescence excitation,
emission and quenching efficiency. Spectral scans of unquenched BODIPY FL-labeled ssRNA
(BoPsi664S) revealed the fluorescence excitation peak at 504 nm and an emission peak at 515
nm (Fig. 2D). Quenched dsRNAs including the siRNA duplex BoPsi664 and duplex DICER
substrates (BoPD664 and BoGD664) share the excitation and emission peaks of the ssRNA
BoPsi664S (Fig. 2D). Efficient quenching was observed for BoGD664 (labeled guide strand of
blunt end dsRNA) at the excitation peak (Q = 0.76) and emission peak (Q = 0.73). Other
dsRNAs had fluorescent label at the opposite end of the duplex. BoPD664 and BoPsi664 (la-
beled passenger strand annealed to strand with 3’-dTdT dinucleotide overhang) had quenching
efficiencies of Q = 0.41 and 0.43 at the excitation peak and Q = 0.46 and 0.47 at the emission
peak. Quenching at a blunt end is more efficient than quenching opposite a strand with
an overhang.
To show generality, we examined fluorogenic dsRNA substrates targeting a different se-
quence (human TYMS gene encoding thymidylate synthase). BODIPY FL-labeled ssRNA
(Bo955-Ra (24 nt), Bo955-Rb (31 nt) or Bo955-Rb5 (10 nt)) was slowly annealed to synthetic
DICER-ARGONAUTE2 Complex in RNAi Fluorogenic Assay
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TYMS RNA, S955 (50 nt) in Table 1. In the presence of 1 mM free Mg2+, annealing of Bo955-
RaS955, Bo955-RbS955 and Bo955-Rb5S955 show fluorimetric Tm of 77.9, 78.3 and 36.3°C,
respectively (Fig. 2E). In the presence of EDTA, annealing of Bo955-RaS955, Bo955-RbS955
and Bo955-Rb5S955 show fluorimetric Tm of 64.7, 65.0 and 27.7°C, respectively (Fig. 2F).
Chelation of divalent cations also shifted melting temperatures of the TYMS duplex series;
Bo955-RaS955, Bo955-RbS955 and Bo955-Rb5S955 show fluorimetric ΔTm of-13.2, -13.3
and-8.6°C, respectively. TYMS-targeting fluorogenic dsRNA substrates shared biophysical
characteristics with the series of HIF1A-targeting of RNAi substrates including thermal stabili-
ty of dsRNA duplexes that increases with dsRNA length and a distinct contribution of divalent
cations to dsRNA stability.
Protein expression and purification
To study enzyme mechanisms in RNA interference, three components of the RISC complex
(recombinant human DICER1, AGO2 and the TARBP2 variant of TRBP were expressed in in-
sect cells and purified with metal affinity and size-exclusion chromatography. SDS-PAGE anal-
ysis (Fig. 3A) shows the purified proteins AGO2, TRBP and DICER had an apparent molecular
weight of 87 kDa, 42 kDa and ~188 kDa, respectively. By mass spectrometry, AGO2 had a mo-
lecular mass of 97,119 compared to the theoretical value of 97,133 for the construct. Purified
TRBP was also confirmed as full length by MS analysis.
Fluorogenic DICER substrates targeting human thymidylate synthase
(TYMS)
DICER activity was monitored using fluorogenic DICER substrates with asymmetric over-
hangs (3’-dinucleotide overhang on anti-sense strand and a 21–28-nt overhang on the sense
strand. After cleavage of BoGD955a and BoGD955b, the labeled duplex products dissociate at
the 37°C assay temperature as indicated by increase in fluorescence intensity (Fig. 3B).
Fig 1. Principle of the fluorogenic enzyme assays. Fluorescent dye (BODIPY FL) conjugated to RNA
duplexed to anti-sense oligonucleotides is quenched by the guanine base of the guanosine nucleotide (black
background) on the strand directly opposite the fluorescent dye. Enzymatic cleavage of RNA strand produces
a thermodynamically unstable duplex product with low melting temperature, which dissociates at assay
temperature (37°C) resulting in increased fluorescence intensity.
doi:10.1371/journal.pone.0120614.g001
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Enzymatic activity (measured by initial rates) was linear with concentration of DICER enzyme
(Fig. 3C). Although the enzymatic reactions contained two-fold differences in enzyme concen-
tration, as reactions proceeded toward the endpoint, fluorescence intensities approached the
same high level, which is consistent with complete enzymatic conversion of substrate to prod-
ucts. In the event of enzyme-substrate binding without catalysis, the observed endpoint fluores-
cent intensities would have differed depending upon DICER concentration as in a binding
assay, but this was not observed. Since the fluorogenic assay of TYMS-targeting substrates was
consistent with DICER enzymatic activity, we expanded the fluorogenic assay to unrelated se-
quences that target theHIF1A gene.
Fluorogenic DICER substrates and siRNA targeting human HIF1A
A series of duplex substrates with a different 19-mer core sequence was designed to serve as
substrates of purified RNAi enzymes (Fig. 1). Fluorogenic DICER substrates were labeled on
Guide Strand (BoGD664) or Passenger Strand (BoPD664), and a fluorogenic siRNA labeled on
Fig 2. Duplex stability during dsRNA annealing andmelting wasmeasured using UV and fluorimetric methods. Single-stranded RNA conjugated to
fluorescent BODIPY FL dye and quencherless ssRNA (200 nM each strand) was slowly annealed (upper panels of A, B, C; blue) or melted (upper panels of
A, B, C; red) as measured by UV-visible spectrophotometer with Peltier temperature controller (Absorbance, 260 nm). Annealing was measured
fluorimetrically using an ABI 7900HT Real Time PCR System (lower panels of A, B, C) with the temperature-dependent concentration of unquenched strand
normalized to unquenched strand concentration at T = 95°C. Duplexes BoGD664 (A), BoPD664 (B), BoPsi664 (C), Bo955-Ra, Rb and Rb5 duplexed to
ssRNA S955 (E, F) were analyzed in Assay Buffer (A-E) or Assay Buffer containing 5 mM EDTA (F). Fluorescence excitation spectra (Em = 560 nm, dashed
curves) and emission spectra (Ex = 440 nm, solid curves) show quenching of dsRNA (BoPsi664, BoPD664 or BoGD664) vs. the control unquenched ssRNA
BoPsi664S with no shift in excitation or emission peaks (D). First derivatives are displayed using dashed lines (A-C, E-F).
doi:10.1371/journal.pone.0120614.g002
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the Passenger Strand (BoPsi664) was prepared (Table 1). Fluorescence intensity was monitored
for enzymatic cleavage of DICER substrates and siRNA by combinations of the purified RNAi
enzymes DICER, AGO2 and the dsRNA-binding protein TRBP, and monitoring of BoGD664
cleavage is shown (Fig. 3D). As expected neither AGO2, TRBP, nor the combination AGO2
+TRBP exhibited any activity upon DICER substrate as measured by initial rates. Purified
Fig 3. “Quencherless” fluorogenic substrates allow real-timemonitoring of enzymatic activity of DICER and reconstituted RISC complex for
enzyme kinetics assays.Recombinant human RNAi proteins were expressed in insect cells, purified and analyzed by SDS-PAGE (2.5 μg/lane) with
Coomassie Blue staining (A). Lanes: SeeBlue Plus2 pre-stained markers (M), DICER (1), TRBP (2) and AGO2 (3). Continuous enzymatic assays of DICER
using fluorogenic substrates (250 nM) bearing asymmetric overhangs (3’-dinucleotide overhang on anti-sense strand and long sense overhang) are shown
(B), and linearity with enzyme concentration is shown (C). Continuous assays of reconstituted human RISC (combinations of purified enzymes) using DICER
substrate BoGD664 (250 nM; D-E) or fluorogenic siRNA (AGO-loading substrate BoPsi664; 250 nM; F). AGO2 increases enzymatic activity of reconstituted
RISC: (DICER+AGO2> DICER alone (E-F). AGO2 or TRBP alone show no activity (E-F). *, p<0.05.
doi:10.1371/journal.pone.0120614.g003
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DICER demonstrated activity with both the DICER substrates labeled on the 5’ end of either
strand (Fig. 3E). For cleavage of DICER substrates, AGO2 was inactive, but the combination of
DICER+AGO2 had higher activity than DICER alone (Fig. 3E) suggesting that the DICER-
AGO2 enzyme complex (a subset of the RISC complex) exhibits functional interactions that
could enhance the processing of DICER substrates. Surprisingly, addition of a third member of
the RISC complex (dsRNA-binding protein TRBP) decreased the apparent fluorogenic activity
of DICER+AGO2 (Fig. 3E). Thus, the DICER-AGO2 enzyme complex enhances the processing
of DICER substrates.
Since siRNA is an intermediate in the RISC pathway, we also tested the fluorogenic siRNA
for processing by RISC components. In AGO2 loading, the product of DICER cleavage
(siRNA) binds to the active site of AGO2 where the Passenger Strand is cleaved and dissociates
leaving the Guide Strand loaded on AGO2. In the AGO2 loading assay, AGO2, TRBP and
AGO2+TRBP did not exhibit any activity upon fluorogenic siRNA, and DICER showed little
activity (Fig. 3F). The combination of DICER+AGO2 enzymes had higher activity than DICER
alone for cleaving the fluorogenic siRNA, and activity was unaffected by TRBP (Fig. 3F). Taken
together, these data suggest functional interactions of the DICER-AGO2 enzyme complex that
both enhance the cleavage of DICER substrates and that enhance processing of the siRNA in-
termediate by AGO2.
Functional interaction of AGO2 and DICER enzymes
The reconstituted RISC complex (combination of AGO2 + DICER enzymes) demonstrated a
synergistic increase in enzymatic activity with both DICER substrates (Fig. 3E) and with
fluorogenic siRNA (Fig. 3F). Enzyme combinations with TRBP did not enhance the apparent
enzymatic activity (Fig. 3E-F).
Interactions in the RISC complex were assessed by titrating DICER enzyme with AGO2 or
TRBP and measuring activity. DICER substrates labeled on the 5’ end of either strand were
cleaved by DICER in an AGO2-dependent manner (Fig. 4A). By contrast, titration of DICER
with TRBP showed a small concentration-dependent decrease in apparent activity (Fig. 4A).
No further increase in enzymatic activity was observed after exceeding a 1:1 molar ratio of
AGO2: DICER (Fig. 4A). Fitting the enzymatic activity curves (Fig. 4A) using the Morrison
equation [17] resulted in low nanomolar dissociation constants, suggesting a functional high-
affinity interaction between AGO2 and DICER enzymes in the reconstituted RISC complex
(Kd,app = 2.2 and 0.54 nM using DICER substrates BoGD664 and BoPD664, respectively). The
DICER + AGO2 enzyme combination cleaved the fluorogenic siRNA in an AGO2-dependent
manner, whereas TRBP had no effect on apparent activity (Fig. 4B). These results suggest that
DICER binds AGO2 in an equimolar ratio and that the DICER-AGO2 enzyme complex dem-
onstrates functional interactions between these enzymes that enhance the processing of DICER
substrates and siRNA intermediates.
Enzyme kinetics
Next, mechanisms that underlie functional interactions of enzyme components of the RISC
complex were investigated using substrates and an intermediate utilized in the enzyme com-
plex. We characterized enzyme kinetics for DICER cleavage and AGO2 loading. Initial rate
data were collected for DICER alone and for combinations of DICER with AGO2 or TRBP
(Fig. 4C-E), and kinetic parameters were listed in Table 2. Using either DICER substrate, nor-
mal Michaelis-Menten kinetics were observed for DICER and DICER+AGO2 enzymes
(Table 2). DICER enzyme cleaved both DICER substrates readily; selectivity was similar for
BoGD664 (kcat/Km = 2360 M
-1 s-1) and BoPD664 (kcat/Km = 1890 M
-1 s-1) in Table 2. However,
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the DICER+AGO2 complex did not process both DICER substrates equally. DICER+AGO2 fa-
vored processing of BoGD664 substrate (relative to BoPD664) as evidenced by improved selec-
tivity (1.8-fold kcat/Km) and 2.6-fold improved apparent Km (Table 2).
Kinetic evidence for binding interactions in reconstituted RISC complex
During processing of dsRNAs in the DICER-AGO2 complex, siRNA is an intermediate (product
of DICER and substrate of AGO2). Because mechanistic detail for siRNA processing in the
DICER-AGO2 complex is unknown, it was of interest to determine experimentally the mecha-
nism by feeding a fluorogenic intermediate (siRNA) into the DICER-AGO2 enzyme complex to
Fig 4. Binding interactions in the RISC complex are functionally determined using enzyme kinetics. DICER-AGO2 binding interaction was assessed
by enzymatic activity assays modeled using the Morrison equation [17]. Titration of DICER (25 nM) with AGO2 enhances enzymatic activity for cleavage of
either fluorogenic DICER substrate (250 nM; A) and the fluorogenic siRNA (AGO-loading substrate; 250 nM;B) apparently via high-affinity binding
interaction. AGO loading is dependent on AGO2 concentration and requires DICER (B). Michaelis-Menten kinetics were observed for DICER and minimal
reconstituted RISC using both DICER substrates (C-D). AGO-loading siRNA exhibited kinetics consistent with a substrate inhibition model (E), whereas
DICER or DICER+TRBP demonstrate minimal enzymatic activity. Lesser apparent fluorogenic activity was observed in combination with the dsRNA-binding
protein TRBP.
doi:10.1371/journal.pone.0120614.g004
Table 2. Kinetic parameters for reconstituted human RISC (37°C).
dsRNA substrate Puriﬁed recombinant RISC proteins Km,app (nM) kcat (s-1) Substrate Inhibition, Ki (nM) kcat / Km,app (M-1 s-1)
BoGD664 DICER 122 2.88×10-4 - 2360
DICER+AGO2 139 5.31×10-4 - 3820
DICER+TRBP 77 2.14×10-4 - 2770
BoPD664 DICER 165 3.11×10-4 - 1890
DICER+AGO2 359 7.68×10-4 - 2140
BoPsi664 DICER 19 6.69×10-6 - 344
DICER+AGO2 74 7.28×10-5 105 979
DICER+TRBP 85 1.16×10-5 - 137
doi:10.1371/journal.pone.0120614.t002
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determine how it is processed. Reconstituted RISC (AGO2+DICER) was supplied increasing
concentrations of the fluorogenic siRNA BoPsi664. At low concentrations of fluorogenic siRNA,
increasing initial rates were observed consistent with Michaelis-Menten kinetics (Fig. 4E, dotted
line). However, as concentrations of fluorogenic siRNA were further increased, the observed ini-
tial rates began to decline (Fig. 4E, solid blue line) and departed from normal Michaelis-Menten
kinetics (Fig. 4E, dotted line). Thus, the observed enzyme kinetics for DICER+AGO2 processing
of BoPsi664 were consistent with substrate inhibition for the BoPsi664 (Fig. 4E) with Ki
(105 nM) at 1.4 times the apparent Km of 74 nM (Table 2). Substrate inhibition observed using
the DICER+AGO2 complex suggests that fluorogenic siRNA binds two classes of sites in the
DICER+AGO2 complex. Occupation of one site by siRNA could inhibit processing at the other
site in the enzyme complex. For example, one fluorogenic siRNAmolecule bound to the active
site of DICER and a second fluorogenic siRNA bound to the active site of AGO2may be in close
proximity. At high concentrations of siRNA, active sites of both enzymes are occupied, and the
direct transfer of DICER-bound siRNA (product) to AGO2 is inhibited by another siRNAmole-
cule already bound as a substrate in the active site of AGO2. The substrate inhibition of DICER-
AGO2 complex by fluorogenic siRNA is consistent with a direct transfer mechanism in which
the product of DICER (siRNA) is directly transferred to AGO2 in the enzyme complex.
Substrate specificity
DICER substrates typically bind DICER enzyme via three key molecular interactions: (1.) the 3’-
dinucleotide overhang binds the PIWI/Argonaute/Zwille (PAZ) domain of DICER, (2.) dsRNA
helix forms electrostatic interactions with the basic binding trench of DICER, and (3.) in DICER’s
active site the dsRNA helix undergoes double-stranded endonucleolytic cleavage leaving the 5’-
terminal nucleotide of the Guide Strand bound by the MID domain of DICER. However, DICER’s
unexpected cleavage of DICER substrate BoPD664 (with increased fluorescence in Fig. 3E, 4D)
could be the result of the blunt end binding near the PAZ domain of DICER resulting in endonu-
cleolytic cleavage near the fluorescent label followed by increased fluorescence signal. DICER sub-
strates that are designed with terminal deoxy dinucleotides on the blunt 3’ terminus of the
passenger strand are reported to be preferentially cleaved by DICER in the intended orientation
[18] resulting in improved potency and efficacy in cultured cells [19]. Therefore, Passenger
Strands that previously contained terminal ribo AG nucleotides (BoGD664 and BoPD664) were
synthesized with terminal deoxy dinucleotides (dAdG) and annealed to form the blunt-ended du-
plexes with RNA. The 3’-dTdT overhang was retained on the Guide Strand (BoGD664dAdG and
BoPD664dAdG). Fluorogenic DICER substrates (200 nM) either with (Fig. 5C-D, G-H) and with-
out (Fig. 5A-B, E-F) the deoxy dinucleotide modification in the Passenger Strand [18] and the
fluorogenic siRNA BoPsi664 (Fig. 5I-J) were assayed for cleavage by reconstituted RISC (DICER
+AGO2) and by Escherichia coli ribonuclease H. No enzymatic activity was observed using recon-
stituted RISC in the presence of EDTA or using RNase H. DICER+AGO2 cleaved the Guide-
Strand labeled DICER substrates (200 nM) at an initial rate ratio of 0.63 (BoGD664dAdG:
BoGD664). Similarly, the ratio of DICER+AGO2 activity for Passenger-Strand labeled substrates
(BoPD664dAdG: BoPD664) was 0.58. These results suggest the DICER substrate design BoPD664
(without the Passenger Strand modification) may have been cleaved in the unintended orientation
42% of the time and support the importance of the Passenger Strand modification.
DICER+AGO2 enzymes cleave fluorogenic substrates into duplex
products that are unstable above 25°C
The products of the enzymatic assays were analyzed by thermal denaturation using an iCycler
iQ5 Real Time system (Bio-Rad Laboratories, Hercules, CA). Substrates without treatment by
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Fig 5. DICER+AGO2 enzymes cleave fluorogenic substrates into duplex products that are unstable at T>25°C. Enzymatic activity (37°C) is shown for
the dsRNA DICER substrates (BoGD664AS *GD664S,A; BoGD664AS-dAdG *GD664S, C; BoPD664S * PD664AS, E; BoPD664S-dAdG * PD664AS,G)
and fluorogenic siRNA BoPsi664 (BoPsi664S * Psi664AS; I) by AGO2 (120 nM) + DICER (30 nM) but not by E. coli RNase H (0.24 U/mL). Melting analysis
shows that only products of DICER+AGO2 cleavage are already melted at T 25°C, whereas control reactions containing either no enzyme or RNAse H
instead of DICER+AGO2 have fluorimetric dsRNA stability (as measured by Tm) that is indistinguishable from Tm of the substrates (B, D, F, H, J). EDTA
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enzymes exhibit distinct melting transitions (Fig. 5, black curves) characteristic of the dsRNA
duplex stability. Control conditions in which magnesium ion (critical for catalysis) is chelated
by EDTA show that substrates treated with enzyme do not result in detectable consumption of
substrate, and the Tm values are 11.5 to 12.0°C lower than conditions containing 1 mM free
Mg++ (Fig. 5B, D, F, H, J; Table 3). However, complete reaction conditions including substrate,
RISC enzymes (AGO2+RISC) and 1 mM free Mg++ resulted in complete consumption of sub-
strate as evidenced by loss of dsRNA melting transition (melting not detectable at T25°C;
Fig. 5B, D, F, H, J; DICER+AGO2). By contrast for control conditions, melting was observed
that was indistinguishable from dsRNA substrate alone (Fig. 5B, D, F, H, J; Control). These re-
sults demonstrate that magnesium-dependent catalysis by DICER+AGO2 enzymes (but not
RNase H control) cleaves the dsRNA DICER substrates and fluorogenic siRNA to yield prod-
ucts that cannot persist as duplexes at assay temperature (37°C). Following cleavage by DICER
and AGO2, the shortened products are unstable duplexes that dissociate, and fluorescence
intensity increases.
Competitive substrate assays
In order to rank the ability of unlabeled RNAi substrates to be processed by enzymes of the
RISC complex, a competitive substrate assay was developed. In competitive AGO2-loading as-
says, a fixed concentration of fluorogenic siRNA substrate was combined with increasing con-
centrations of unlabeled DICER substrates or unlabeled siRNA. The DICER-AGO2 complex
was added, and reaction progress was monitored to measure the apparent (fluorogenic) initial
rates of reaction. The enzymatic rates for reconstituted RISC exhibited competition was depen-
dent on the concentrations of competing unlabeled DICER substrate (D03) as low as 25 nM
(Fig. 6A, upper panel) compared to control without unlabeled substrate (Fig. 6A, Control). By
contrast, higher concentrations (100 nM) of the unlabeled DICER substrate D10 were re-
quired to affect the initial rate of AGO loading. The apparent fluorogenic initial rates for AGO
loading were found to decrease with increasing concentrations of unlabeled DICER substrates
(D03, D11, D10) or unlabeled AllStars siRNA compared to the control without unlabeled sub-
strate (Fig. 6B, diamond). This result is consistent with alternative substrate (unlabeled siRNA
or unlabeled DICER substrate) competing with fluorogenic substrate for the AGO2 enzyme ac-
tive site. The rank order of potency of unlabeled DICER substrates in the competitive AGO2-
loading assay was D03> D11> AllStars siRNA> D10.
Correlation of enzymatic assay for competitive AGO2 loading in vitro vs.
cell-based RNA interference assay
To evaluate biological relevance, the enzymatic assay of competitive AGO2 loading of unla-
beled DICER substrates by the DICER•AGO2 complex was tested vs. a cell-based assay of
HIF1AmRNA knockdown. A series of DICER substrates was tested for knockdown ofHIF1A
mRNA in Huh-7.5 cells. For bDNA detection of HIF1A knockdown reveals an observed rank
order of potency (IC50) for the DICER substrates (D03> D11> D10), which was consistent
with rank order in the competitive enzyme assay for AGO2 loading in reconstituted RISC
(Table 4). The control (non-silencing AllStars siRNA) did not knock down HIF1AmRNA in
the cell assay. As expected, however, AllStars siRNA competed with the fluorogenic siRNA for
AGO2 loading in the enzyme assay (IC50 = 209±69 nM; Table 4). Competitive AGO loading
inhibits enzymatic cleavage of substrates and gives the characteristic decrease in Tm compared to Assay Buffer containing divalent cations (B, D, F, H, J).
First derivatives are displayed using dashed lines.
doi:10.1371/journal.pone.0120614.g005
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(enzymatic IC50 in vitro) of unlabeled DICER substrates by the DICER•AGO2 complex was
correlated with potency (EC50) in the cell-based assay of HIF1AmRNA knockdown (Fig. 6C).
The DICER substrate series shows a log-log correlation slope of 0.29. Thus among members of
the DICER substrate series, a 10-fold improvement in the relative ability of substrate to be pro-
cessed and loaded onto AGO2 has a strong (~2800-fold) effect upon potency for mRNA
knockdown, which may reflect catalytic degradation of multiple mRNA copies by each AGO2-
Guide Strand complex. The enzyme kinetics assay suggests that certain sequence-specific as-
pects of the tested designs of DICER substrates were more compatible for processing by the
DICER•AGO2 complex for loading AGO2 with the appropriate Guide Strand, and these re-
sults were correlated with knockdown in the cell assay.
Discussion
This study describes mechanistic details for RNA processing by enzymes of the human RISC
complex. New mechanistic findings in RNAi were made possible by the development of con-
tinuous enzymatic assays that provided detailed enzyme kinetics data. Fluorogenic substrates
were synthesized comprising a fluorescent strand (ssRNA covalently attached BODIPY FL
fluorescent dye) annealed to a complementary ssRNA. Annealing of the BODIPY FL-labeled
cytosine residue to guanosine of the complementary strand causes fluorescence quenching by
the guanosine base. The resulting “quencherless” fluorogenic substrates allowed continuous
enzymatic assays of DICER and AGO2 for enzyme kinetics studies. We studied fluorogenic
substrates targeting two different human genes (TYMS and HIF1A) and determined that par-
ticular combinations of proteins of the RISC complex can process certain dsRNA structures.
Purified DICER enzyme (but not AGO2) cleaves fluorogenic DICER substrates, and the com-
bination DICER+AGO2 (enzyme components of the RISC complex) synergistically increases
the enzymatic activity via a functional high-affinity interaction between DICER and AGO2 en-
zymes. Addition of a third RISC component, the dsRNA-binding protein TRBP slightly de-
creased the apparent fluorogenic activity. DICER and DICER+AGO2 activity upon DICER
substrates exhibited Michaelis-Menten kinetics. These results suggest that interactions in the
DICER+AGO2 complex are important for processing DICER substrates. We further studied
the interaction using siRNA, an intermediate in the RISC pathway. The combination of DICER
+AGO2 enzymes (but not AGO2) cleaved fluorogenic siRNA, and the addition of TRBP did
not affect the apparent enzymatic activity. The finding of substrate inhibition for DICER
+AGO2 processing of fluorogenic siRNA suggests that the siRNA binds two sites during pro-
cessing, most likely the active sites of the two enzymes. These data are consistent with a direct
Table 3. RNA duplex stability (Tm) measured by ﬂuorescence quenching of BODIPY FL-labeled RNA.
Duplex Observed Tm (°C) Calculated Tm (°C)
Substrate + Mg++ (1
mM)
Substrate, Mg-free
(EDTA)
Substrate + Mg++ (1
mM)
DICER+AGO2 Product + Mg++ (1
mM)
BoGD664 (200 nM) 84.7 72.7 77.9 15.0
BoGD664dAdG (200 nM)* 84.0 72.0 77.1 <10
BoPD664 (200 nM) 84.8 73.0 77.9 24.7
BoPD664dAdG (200 nM)
*
83.8 72.3 77.1 24.7
Psi664 (80 nM) 73.0 61.3 64.3 24.7
* Right (“R”) DICER substrate with two deoxyribonucleotides on the 5’ terminus of sense strand [18].
doi:10.1371/journal.pone.0120614.t003
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transfer mechanism in the DICER+AGO2 enzyme complex in which the siRNA product
bound at the active site of DICER is directly transferred to the active site of AGO2 in the en-
zyme complex. The fluorogenic siRNA substrate was also used in competitive substrate assays
to evaluate processing of unlabeled dsRNA therapeutic molecules by RNAi enzymes. In the
competitive AGO2-loading assay, unlabeled synthetic dsRNAs (DICER substrates) were
Fig 6. Competitive ARGONAUTE2 loading in the DICER-AGO2 enzyme complex correlates with efficacy in cell-based RNAi assays. Kinetic assays
of enzymatic AGO loading were performed by applying DICER+AGO2 (30 nM each) to mixtures containing a fixed concentration of fluorogenic AGO
substrate (siRNA BoPsi664, 80 nM) and variable concentrations (0, 25, 100, 400 nM shown) of unlabeled competing DICER substrate D03 (A, panel above)
or DICER substrate D10 (A, panel below). “No enzyme” control wells contain BoPsi664 without DICER or AGO2. The apparent initial rate of fluorogenic AGO
loading was dependent upon the concentration of unlabeled competing DICER substrates D03, D10 and D11 (B, colored symbols) or unlabeled competing
AGO substrate (B, AllStars siRNA) compared to control (B, “Ctrl”). The potency of competitive AGO loading of DICER substrates by the DICER-AGO2
complex (IC50) was correlated toHIF1AmRNA in Huh-7.5 cells as detected by branched DNA (bDNA) assay (C). Dotted lines indicate the 90% confidence
interval, and error bars show SEM. “n.d.,” not detectable.
doi:10.1371/journal.pone.0120614.g006
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processed by DICER+AGO2 in competition with fluorogenic siRNA substrate. Unlabeled
DICER substrates caused a concentration-dependent decrease in fluorogenic initial rates with
in vitro IC50 values that correlate with HIF1AmRNA knockdown in Huh-7.5 cells. This result
suggests that certain DICER substrate sequences had decreased efficacy in RNAi due to their
poor ability to be processing by enzymes of the RISC complex. Finally, fluorogenic DICER sub-
strates and fluorogenic siRNA were cleaved by DICER+AGO2 enzymes in a magnesium-
dependent manner, and cleavage products do not exist as duplexes at assay temperature. We
present a new method for studying mechanistic detail of RNAi enzymes using continuous en-
zyme assays. These data support the importance of the DICER+AGO2 enzyme complex for
processing dsRNA molecules in the RNAi pathway. This method can be used to experimentally
determine structure-activity relationships for synthetic dsRNA molecules including chemical
modifications in order to diagnose issues with DICER cleavage and AGO2 loading.
This is the first study to demonstrate continuous monitoring for processing of dsRNA sub-
strates by both DICER and AGO2 enzymes, which catalyze sequential steps in the RNAi path-
way. Enzyme kinetics analysis revealed new findings regarding mechanism in the RISC
complex. Continuous assays using dsRNA substrates show that enzymatic activity is function-
ally dependent upon high-affinity interaction between DICER and AGO2 enzymes. Further,
enzyme kinetics using fluorogenic substrates provide evidence for a model in which the siRNA
Table 4. Competitive AGO2-loading enzymatic assay in vitro vs. knockdown of HIF1A mRNA in Huh 7.5 cells (bDNA assay).
Competing
substrate
dsRNA sequence HIF1A mRNA knockdown
(bDNA assay) EC50 (nM)
AGO2-loading by competitive
enzymatic assay IC50 (nM)
D03 5'- CCGGUUGAAUCUUCAGAUAUGAAAA-3'
3'-UUGGCCAACUUAGAAGUCUAUACUUUU-5'
0.024 150
D02 5'- GCUGAUUUGUGAACCCAUUCCUCAC-3'
3'-CACGACUAAACACUUGGGUAAGGAGUG-5'
0.026 142
D01 5'- ACCGGUUGAAUCUUCAGAUAUGAAA-3'
3'-UUUGGCCAACUUAGAAGUCUAUACUUU-5'
0.030 56
D04 5'- GUUCCUGAGGAAGAACUAAAUCCAA-3'
3'-GUCAAGGACUCCUUCUUGAUUUAGGUU-5'
0.038 180
D05 5'- GGAACAUGAUGGUUCACUUUUUCAA-3'
3'-UACCUUGUACUACCAAGUGAAAAAGUU-5'
0.038 209
D11 5'-ACCUGAGCCUAAUAGUCCCAGUGAAUA-3'
3'-UGGACUCGGAUUAUCAGGGUCACUU-5'
0.29 364
D12 5'-UACUCAGGACACAGAUUUAGACUUGGA-3'
3'-AUGAGUCCUGUGUCUAAAUCUGAAC-5'
1.1 453
D07 5'- GGAUAAAAUUCUCAAUUCAGAGAAA-3'
3'-AACCUAUUUUAAGAGUUAAGUCUCUUU-5'
2.0 282
D10 5'-CCUGAGGAAGAACUAAAUCCAAAGAUA-3'
3'-GGACUCCUUCUUGAUUUAGGUUUCU-5'
6.5 633
D06 5'- GGAUAGUGAUAUGGUCAAUGAAUUC-3'
3'-CACCUAUCACUAUACCAGUUACUUAAG-5'
7.2 474
D09 5'-CAGACACCUAGUCCUUCCGAUGGAAGC-3'
3'-GUCUGUGGAUCAGGAAGGCUACCUU-5'
n.d. 767
D25 5'-GCACCCCCACCUCUGGACUUGCCUUUC-3'
3'-CGUGGGGGUGGAGACCUGAACGGAA-5'
n.d. 796
D08 5'-CCAGAAGAACUUUUAGGCCGCUCAAUU-3'
3'-GGUCUUCUUGAAAAUCCGGCGAGUU-5'
n.d. 1060
AllStars Proprietary siRNA (Qiagen, Inc.) n.d. 209
n.d.: Not detectable.
doi:10.1371/journal.pone.0120614.t004
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product of DICER is directly transferred to the active site of AGO2 enzyme in the RISC com-
plex. Finally, the new fluorogenic assays demonstrate that unlabeled therapeutic RNAi mole-
cules (e.g. synthetic dsRNA molecules) can be tested in vitro for their ability to be processed by
DICER enzyme followed by AGO2 enzyme (AGO-loading activity), which correlates with
mRNA knockdown activity in a cell-based RNAi assay.
Loading of AGO2 appears to occur by two pathways (de novo and reloading pathways). In
the de novo pathway, DICER produces an siRNA molecule. The siRNA is transferred from the
active site of DICER to its binding partner in the RISC complex, AGO2. Functionally in the
RISC complex, AGO2 assumes a conformation that is competent for dsRNA binding and for
cleavage. Passenger strand cleavage would result in AGO2 activation by programming AGO2
with the Guide Strand bound at the active site. Complexes of enzymes that catalyze sequential
steps in an enzymatic pathway can improve flux through that pathway via direct transfer of the
product of the first enzyme to the active site of the second enzyme. It would be most efficient
for AGO2 activation if the siRNA product in DICER’s active site is transferred directly to
AGO2 instead of being diluted into a cytoplasmic pool of ssRNA that is subject to ribonuclease
degradation before it can accumulate to nanomolar concentrations (Kd 61 nM reported in
reference [20] for loading onto AGO2). In the current study, substrate inhibition of AGO2-
DICER complex using the fluorogenic siRNA could be explained by substrate binding to both
AGO2 and DICER. The substrate inhibition observed in our study is consistent with the EM
model for direct transfer in which opposite ends of an siRNA are each bound to the respective
PAZ domains of the AGO2-DICER complex [21].
The second pathway for AGO2 loading is the reloading pathway, which would occur after
the Guide Strand dissociates from the active site of AGO2. Guide-Strand loading onto AGO2
enzyme [20] in the absence of DICER would really be a reloading process that draws from a cy-
toplasmic pool of ssRNA Guide Strands. The released guide strands are very short and may
lack structures such as the 5’-terminal 7-methylguanosine cap or 3’-polyadenylation that nor-
mally provides protection of mRNAs from exoribonucleases [22–24]. Therefore, guide strands
of the cytoplasmic pool could be susceptible to degradation by intracellular ribonucleases,
which would tend to decrease the importance of the reloading pathway. The AGO2-DICER
complex mechanism could explain published observations that ssRNA can be loaded onto
AGO2 and that dsRNA is not loaded due to poor binding by AGO2 alone [20], whereas
dsRNA is loaded efficiently onto AGO2 in the AGO2-DICER complex.
“Quencher-less” fluorogenic assays offer benefits over current methodologies. RNAi is a
complex, multi-step enzymatic pathway, and existing technologies typically do not allow indi-
vidual activities in the pathway to be studied at large scale. Currently, assaying RNAi involves
endpoint analysis at discrete time points that is expensive and/or labor-intensive usually in-
volving radioactivity or PCR. Those methods provide a readout that must span the entire
multi-step enzymatic pathway. By contrast, the current study can dissect the enzymatic path-
way into smaller steps to determine where in the pathway that synthetic RNAi molecules func-
tion or fail to function. Novel continuous fluorogenic assays of ARGONAUTE loading and
DICER enzymatic activity were developed to assess RNAi entities using reconstituted RISC
from purified recombinant human enzymes. The new quencher-less method also minimizes
perturbation of enzymatic activity by avoiding potential steric issues with bulky quencher mol-
ecules (typically large, fused aromatic systems) such as those required in a fluorogenic assay
format for endonuclease assays of RNase H [25] and DICER [26]. Another report of fluorimet-
ric detection of DICER activity relies on shifts in autocorrelation curves by fluorescence corre-
lation spectroscopy [27]. One report has been published for fluorimetric detection of AGO2
Slicer activity [28], which is the enzymatic step immediately downstream of the DICER and
AGO2-loading activities of the current report. Published applications that utilize quenching of
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BODIPY FL-labeled oligonucleotides are limited to PCR methods [14–16]. The quenching effi-
ciencies of the four bases for many different fluorescent dyes including BODIPY FL have been
tabulated, and of the four bases, guanosine was the best quencher [29,30]. Singlet-excited BOD-
IPY FL is quenched by guanine through a photoinduced electron-transfer (PET) mechanism,
which requires contact of excited fluorescent dye with quencher (van der Waals contact) for ef-
ficient quenching [29]. For DNA-BODIPY FL and dG in DNA duplexes, the charge separation
that occurs during PET is fully reversible [29], which assures quantitative analysis in
quenching studies.
Limitations of this study include a 3’-dTdT overhang in the fluorogenic substrates instead
of the di-ribonucleotide overhang found in physiological DICER substrates. Since bases and ri-
bose rings of the overhang nucleotides affect binding at the PAZ domain, the deoxynucleotide
overhang could affect the enzyme kinetic parameters compared to physiological substrates of
DICER and/or AGO2. Given that the physiological substrates of DICER and AGO can have
many different sequences, the synthetic sequences of the fluorogenic substrates might also af-
fect the enzyme kinetic parameters. However, those considerations do not negate the mecha-
nistic findings for DICER and AGO2 in this study nor do they negate the utility of fluorogenic
substrates for evaluation of the ability of synthetic RNAi molecules to compete with a given
fluorogenic substrate molecule for processing by DICER+AGO2. Another limitation is that re-
constituted RISC complex contains the dsRNA-binding protein TRBP in addition to DICER
and AGO2 [4]. TRBP did not improve the apparent enzymatic activity of reconstituted RISC
(DICER+AGO2) in this study; TRBP was dispensable as it is not required for dsRNA process-
ing in the RISC complex in vitro [8,9].
Conclusions
DICER and AGO2 enzymes form a functional equimolar complex with high affinity. This min-
imal RISC complex supports siRNA loading onto AGO2, whereas AGO2 does not efficiently
self-load/cleave a double-stranded siRNA. Enzyme kinetics study of the minimal RISC sup-
ports a model in which the product of DICER is transferred directly to AGO2. “Quencherless”
fluorogenic assays for enzymatic activity of DICER and AGO2-loading activity provide for
continuous monitoring of RNAi enzymatic activity and enable detailed kinetic analysis on a
scale that was previously not possible. These studies lay the foundation for a systematic bio-
chemical approach to the DICER-AGO2 enzyme pathway for providing structure-activity rela-
tionships of duplex designs that correlate with mRNA knockdown in cell assays. Designs of
RNAi molecules with low propensity to be loaded onto AGO2 can have limited effectiveness in
RNAi-mediated knockdown. Conversely, an RNAi design with better efficiency for loading
onto AGO2 can greatly amplify its effectiveness through the degradation of many mRNA mol-
ecules in multiple catalytic rounds of cleavage by AGO2 enzyme. The in vitro enzymatic assay
of ARGONAUTE2 loading of DICER substrates was correlated with cell-based assay of mRNA
knockdown, suggesting that improved DICER substrate designs with 10-fold greater process-
ing by the DICER+AGO2 complex can provide a strong (~2800-fold) improvement in potency
for mRNA knockdown. Optimizing the in vitro activity in designs of nucleic acid-based thera-
peutics is aimed at improving efficacy in the cell.
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